(Q50993625)
Statements
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up (English)
Carlos Nos
Francesc Xavier Aymerich
Luis Brieva
Nieves Téllez
Héctor Perkal
Manuel Comabella
David Calle
1 November 2011